Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study
Published inFrontiers in cardiovascular medicine, vol. 9, 817826
Publication date2022
First online date2022-03-17
Abstract
Keywords
- Anti-Xa assay
- Diagnostic accuracy
- Direct oral anticoagulants
- Laboratory monitoring
- Rivaroxaban
Affiliation entities
Research groups
Citation (ISO format)
MEIHANDOEST, Tamana et al. Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study. In: Frontiers in cardiovascular medicine, 2022, vol. 9, p. 817826. doi: 10.3389/fcvm.2022.817826
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:167073
- DOI : 10.3389/fcvm.2022.817826
- PMID : 35369293
- PMCID : PMC8969025
ISSN of the journal2297-055X